Literature DB >> 24496923

Working-age adults with diabetes experience greater susceptibility to seasonal influenza: a population-based cohort study.

Darren Lau1, Dean T Eurich, Sumit R Majumdar, Alan Katz, Jeffrey A Johnson.   

Abstract

AIMS/HYPOTHESIS: The aim of this work was to compare the incidence of illness attributable to influenza in working-age adults (age <65 years) with and without diabetes.
METHODS: We performed a cohort study using administrative data from Manitoba, Canada, between 2000 and 2008. All working-age adults with diabetes were identified and matched with up to two non-diabetic controls. We analysed the rates of influenza-like illness physician visits and hospitalisations, pneumonia and influenza hospitalisations, and all-cause hospitalisations. Multivariable regressions were used to estimate the influenza-attributable rate of each outcome.
RESULTS: We included 745,777 person-years of follow-up among 166,715 subjects. The median age was 50-51 years and 48-49% were women; adults with diabetes had more comorbidities and were more likely to be vaccinated for influenza than those without diabetes. Compared with similar adults without diabetes, those with diabetes had a 6% greater (RR 1.06, 95% CI 1.02, 1.10; absolute risk difference 6 per 1,000 adults per year) increase in all-cause hospitalisations associated with influenza, representing a total of 54 additional hospitalisations. There were no differences in the influenza-attributable rates of influenza-like illness (p = 0.06) or pneumonia and influenza (p = 0.11). CONCLUSIONS/
INTERPRETATION: Guidelines calling for influenza vaccinations in diabetic, in addition to elderly, adults implicitly single out working-age adults with diabetes. The evidence supporting such guidelines has hitherto been scant. We found that working-age adults with diabetes appear more susceptible to serious influenza-attributable illness. These findings represent the strongest available evidence for targeting diabetes as an indication for influenza vaccination, irrespective of age.

Entities:  

Mesh:

Year:  2014        PMID: 24496923     DOI: 10.1007/s00125-013-3158-8

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  44 in total

1.  Evidence of bias in estimates of influenza vaccine effectiveness in seniors.

Authors:  Lisa A Jackson; Michael L Jackson; Jennifer C Nelson; Kathleen M Neuzil; Noel S Weiss
Journal:  Int J Epidemiol       Date:  2005-12-20       Impact factor: 7.196

2.  Clinical effectiveness of first and repeat influenza vaccination in adult and elderly diabetic patients.

Authors:  Ingrid Looijmans-Van den Akker; Theo J M Verheij; Erik Buskens; Kristin L Nichol; Guy E H M Rutten; Eelko Hak
Journal:  Diabetes Care       Date:  2006-08       Impact factor: 19.112

3.  Clinical characteristics and outcomes of diabetic patients who were hospitalised with 2009 pandemic influenza A H1N1 infection.

Authors:  Marta Cortes Garcia; Maria Jose Sierra Moros; Patricia Santa-Olalla Peralta; Valentin Hernandez-Barrera; Rodrigo Jimenez-Garcia; Isabel Pachon
Journal:  J Infect       Date:  2011-11-25       Impact factor: 6.072

4.  Effect of epidemic influenza on ketoacidosis, pneumonia and death in diabetes mellitus: a hospital register survey of 1976-1979 in The Netherlands.

Authors:  K P Bouter; R J Diepersloot; L K van Romunde; R Uitslager; N Masurel; J B Hoekstra; D W Erkelens
Journal:  Diabetes Res Clin Pract       Date:  1991-04       Impact factor: 5.602

5.  Co-morbidities associated with influenza-attributed mortality, 1994-2000, Canada.

Authors:  Dena L Schanzer; Joanne M Langley; Theresa W S Tam
Journal:  Vaccine       Date:  2008-07-11       Impact factor: 3.641

6.  Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009.

Authors:  Seema Jain; Laurie Kamimoto; Anna M Bramley; Ann M Schmitz; Stephen R Benoit; Janice Louie; David E Sugerman; Jean K Druckenmiller; Kathleen A Ritger; Rashmi Chugh; Supriya Jasuja; Meredith Deutscher; Sanny Chen; John D Walker; Jeffrey S Duchin; Susan Lett; Susan Soliva; Eden V Wells; David Swerdlow; Timothy M Uyeki; Anthony E Fiore; Sonja J Olsen; Alicia M Fry; Carolyn B Bridges; Lyn Finelli
Journal:  N Engl J Med       Date:  2009-10-08       Impact factor: 91.245

7.  Influenza-associated hospitalizations in the United States.

Authors:  William W Thompson; David K Shay; Eric Weintraub; Lynnette Brammer; Carolyn B Bridges; Nancy J Cox; Keiji Fukuda
Journal:  JAMA       Date:  2004-09-15       Impact factor: 56.272

8.  Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009.

Authors:  Carrie Reed; Frederick J Angulo; David L Swerdlow; Marc Lipsitch; Martin I Meltzer; Daniel Jernigan; Lyn Finelli
Journal:  Emerg Infect Dis       Date:  2009-12       Impact factor: 6.883

9.  The burden of community-acquired pneumonia in seniors: results of a population-based study.

Authors:  Michael L Jackson; Kathleen M Neuzil; William W Thompson; David K Shay; Onchee Yu; Christi A Hanson; Lisa A Jackson
Journal:  Clin Infect Dis       Date:  2004-11-08       Impact factor: 9.079

10.  Viral infection in adults hospitalized with community-acquired pneumonia: prevalence, pathogens, and presentation.

Authors:  Jennie Johnstone; Sumit R Majumdar; Julie D Fox; Thomas J Marrie
Journal:  Chest       Date:  2008-08-08       Impact factor: 9.410

View more
  8 in total

1.  Diabetes mellitus and treatment outcomes of pulmonary tuberculosis: a cohort study.

Authors:  Serine Sahakyan; Varduhi Petrosyan; Lusine Abrahamyan
Journal:  Int J Public Health       Date:  2019-06-25       Impact factor: 3.380

2.  Recommendations of the Italian society for infectious and tropical diseases (SIMIT) for adult vaccinations.

Authors:  Massimo Andreoni; Laura Sticchi; Silvia Nozza; Loredana Sarmati; Andrea Gori; Marcello Tavio
Journal:  Hum Vaccin Immunother       Date:  2021-09-15       Impact factor: 4.526

3.  Is population structure sufficient to generate area-level inequalities in influenza rates? An examination using agent-based models.

Authors:  Supriya Kumar; Kaitlin Piper; David D Galloway; James L Hadler; John J Grefenstette
Journal:  BMC Public Health       Date:  2015-09-23       Impact factor: 3.295

4.  Diabetes Mellitus and Cause-Specific Mortality: A Population-Based Study.

Authors:  Sen Li; Jiaxin Wang; Biao Zhang; Xinyi Li; Yuan Liu
Journal:  Diabetes Metab J       Date:  2019-06       Impact factor: 5.376

5.  Quantifying the Impact of Influenza Among Persons With Type 2 Diabetes Mellitus: A New Approach to Determine Medical and Physical Activity Impact.

Authors:  Sandrine I Samson; Kevin Konty; Wei-Nchih Lee; Tom Quisel; Luca Foschini; David Kerr; Jan Liska; Henry Mills; Rosalind Hollingsworth; Michael Greenberg; Anne C Beal
Journal:  J Diabetes Sci Technol       Date:  2019-11-20

6.  Vaccination coverage of patients with type 2 diabetes mellitus: Challenging issues from an outpatient secondary care setting in Greece.

Authors:  Georgios Galanos; Helen Dimitriou; Angelos Pappas; Chrysoula Perdikogianni; Emmanouil K Symvoulakis; Emmanouil Galanakis; Christos Lionis
Journal:  Front Public Health       Date:  2022-08-01

7.  Temporal trends in rates of infection-related hospitalisations in Hong Kong people with and without diabetes, 2001-2016: a retrospective study.

Authors:  Andrea O Y Luk; Hongjiang Wu; Eric S H Lau; Aimin Yang; Wing-Yee So; Elaine Chow; Alice P S Kong; David S C Hui; Ronald C W Ma; Juliana C N Chan
Journal:  Diabetologia       Date:  2020-09-28       Impact factor: 10.122

8.  Type 1 Diabetes Patients' Practice, Knowledge and Attitudes towards Influenza Immunization.

Authors:  Giulia Dallagiacoma; Agnese Allora; Stefano Salvati; Giulia Cocciolo; Michele Capraro; Anna Lamberti; Sabrina Senatore; Leandro Gentile; Vincenza Gianfredi; Andrea Laurenzi; Chiara Molinari; Amelia Caretto; Marino Faccini; Carlo Signorelli; Marina Scavini; Anna Odone
Journal:  Vaccines (Basel)       Date:  2021-06-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.